Commercial advertising or promotion

AND · 15usc1125:commercial-promotion

Commercial speech disseminated to the relevant purchasing audience to influence buying. A false statement in any private dispute or investor communication is not automatically advertising. Genus’s old circuit formulation included competition; do not import that as a universal bar after Lexmark or later circuit decisions. Advertising/promotion remains an independent statutory requirement.

Exact element source

(B) in commercial advertising or promotion, misrepresents the nature, characteristics, qualities, or geographic origin of his or her or another person’s goods, services, or commercial activities,
Source: docroot/ir/usc/title15.jsonl#title15_sec1125; Unicode character offsets [674:869] (end exclusive); SHA-256 0a5680239d11ae3247a99abab2344db45177346d2d2e3050e95c82fb39f3aca7.

All variants

Recorded DB variant labels, including zero-count variants
VariantDescriptionMerits instance blocksDistinct casesExample cases (up to 3 per group)
assumed-coverage/letters-and-cartridge-notices0
Satisfied 0; not satisfied 0; excluded context 1
0No counted merits examples

Excluded context examples: /us/572/0118-01 — Supreme Court of the United States · 2014 — applied/merits

audience/investor-filings-and-calls1
Satisfied 0; not satisfied 1; excluded context 0
1/f-supp-3d/378/0823-01 — United States District Court for the Northern District of California · 2019 — not

How courts decided this element

Annotation blocks, including explicitly excluded context
CaseElementHolding and scopeVariantExact source quotations
/f-supp-3d/378/0823-01 — United States District Court for the Northern District of California · 2019Commercial advertising or promotionnot
Counted merits instance
applied / merits

basis: pleaded; party: Genus against Lannett; count: Grandfathered and preliminary-NDA statements; subject: party=Genus against Lannett; count=Grandfathered and preliminary-NDA statements

Failure concerns purpose and dissemination, not an absolute SEC-filing exemption. The older cited competition formulation is not adopted as a universal post-Lexmark requirement.
audience/investor-filings-and-calls
Nevertheless, Lannett claimed that C-Topical was grandfathered in a number of Securities and Exchange Commission ("SEC") filings and investor calls in between December 2017 and September 2018.
Source: docroot/ir/caselaw/f_supp_3d_378.jsonl#/f-supp-3d/378/0823-01; Unicode character offsets [6179:6371] (end exclusive); SHA-256 cecb4fb9356fb3ba0c59f5db0729643e572e7c328d93987db6eb8bd51b3f3a87.

Evidence kind: fact; polarity: cuts-against; absent flag: 0; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

Although the procedural posture in RPost is different, Genus has failed to allege (rather than prove as in RPost ) that the SEC statements and investor calls were made for the purpose of influencing consumers to buy its goods or services, or that they were disseminated sufficiently to pharmacists, doctors, and hospital groups.
Source: docroot/ir/caselaw/f_supp_3d_378.jsonl#/f-supp-3d/378/0823-01; Unicode character offsets [27906:28234] (end exclusive); SHA-256 cecb4fb9356fb3ba0c59f5db0729643e572e7c328d93987db6eb8bd51b3f3a87.

Evidence kind: fact; polarity: cuts-against; absent flag: 1; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

But in order to be actionable, the statements must be accompanied by specific allegations that they were made for the purpose of influencing the customers of cocaine hydrochloride solutions to buy C-Topical, or were disseminated sufficiently to the relevant purchasing public (pharmacists, hospitals, and doctors) to constitute "advertising" or "promotion" within the pharmaceutical industry.
Source: docroot/ir/caselaw/f_supp_3d_378.jsonl#/f-supp-3d/378/0823-01; Unicode character offsets [30196:30588] (end exclusive); SHA-256 cecb4fb9356fb3ba0c59f5db0729643e572e7c328d93987db6eb8bd51b3f3a87.

Evidence kind: rule; polarity: not recorded; absent flag: 0; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

I find that the allegations contained in the SEC filings and investor calls stating that C-Topical is "grandfathered" or under a "preliminary new drug application" cannot, without more, state a claim for Lanham Act false advertising because they do not rest on any statements made in advertising or promotion.
Source: docroot/ir/caselaw/f_supp_3d_378.jsonl#/f-supp-3d/378/0823-01; Unicode character offsets [30614:30923] (end exclusive); SHA-256 cecb4fb9356fb3ba0c59f5db0729643e572e7c328d93987db6eb8bd51b3f3a87.

Evidence kind: held; polarity: not recorded; absent flag: 0; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

/us/572/0118-01 — Supreme Court of the United States · 2014Commercial advertising or promotionnot_reached
Excluded from merits counts
applied / merits

An express assumption reserved from review, not a pleaded finding of commercial promotion. Not-reached excludes this unpresented issue from instances.
assumed-coverage/letters-and-cartridge-notices
We assume without deciding that the communications alleged by Static Control qualify as commercial advertising or promotion.
Source: docroot/ir/caselaw/us_572.jsonl#/us/572/0118-01; Unicode character offsets [37567:37691] (end exclusive); SHA-256 925bbd2e7ac80af005ca0208b672687190e36af5f681de2bd2a157b522bc7810.

Evidence kind: held; polarity: not recorded; absent flag: 0; quoted-rule flag: 0 (1 = tagged; 0 = not tagged)

Court interpretations